Zai Lab Ltd - ADR
General ticker "ZLAB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.7B
Zai Lab Ltd - ADR follows the US Stock Market performance with the rate: 31.7%.
Estimated limits based on current volatility of 1.9%: low 25.91$, high 26.90$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.22$, 38.07$]
- 2024-12-30 to 2025-12-30 estimated range: [16.86$, 36.79$]
Financial Metrics affecting the ZLAB estimates:
- Negative: Non-GAAP EPS, $ of -3.45 <= 0.10
- Negative: Operating profit margin, % of -57.88 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -6.87 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ZLAB quotes
Long-term ZLAB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $144.31MM | $215.04MM | $266.72MM |
| Operating Expenses | $844.38MM | $619.40MM | $633.29MM |
| Operating Income | $-700.06MM | $-404.36MM | $-366.57MM |
| Non-Operating Income | $-3.35MM | $-38.71MM | $31.95MM |
| Interest Expense | $0.00MM | $14.58MM | $0.00MM |
| R&D Expense | $573.31MM | $286.41MM | $265.87MM |
| Income(Loss) | $-703.41MM | $-443.06MM | $-334.62MM |
| Other Income(Loss) | $-1.06MM | $-0.22MM | $0.00MM |
| Profit(Loss) | $-704.47MM | $-443.29MM | $-334.62MM |
| Stockholders Equity | $1,379.96MM | $1,045.60MM | $796.12MM |
| Inventory | $18.95MM | $31.62MM | $44.83MM |
| Assets | $1,609.96MM | $1,220.14MM | $1,036.30MM |
| Operating Cash Flow | $-549.23MM | $-367.64MM | $-198.18MM |
| Capital expenditure | $18.95MM | $24.98MM | $8.49MM |
| Investing Cash Flow | $249.96MM | $420.02MM | $-10.78MM |
| Financing Cash Flow | $820.20MM | $-1.73MM | $-6.43MM |
| Earnings Per Share* | $-7.45 | $-5.03 | $-3.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.